AdvanDx / OpGen A/S

Gungevej 2, 2, 2650 Hvidovre
Denmark [incl. Greenland]

Telephone +45 45 160799

This company is co-exhibitor of
Confederation of Danish Industry


Hall map

MEDICA 2016 hall map (Hall 16): stand D41

Fairground map

MEDICA 2016 fairground map: Hall 16

Our range of products

Product categories

  • 03  Diagnostics
  • 03.04  Microbiology
  • 03.04.02  Bacteriology - Identification and susceptibility testing

Bacteriology - Identification and susceptibility testing

Our products

Product category: Bacteriology - Identification and susceptibility testing


Rapid, Actionable Information for Treating Bloodstream Infections

QuickFISH tests are FAST and EASY with a 20 minute turn-around time and 5 minutes of hands-on time. Results can be reported at the same time labs make the critical Gram Stain call. Our proprietary platform of QuickFISH tests help hospitals reduce time to appropriate therapy, avoid unnecessary antibiotic use, improve patient outcomes and lower hospital costs.1,2

QuickFISH provides rapid and accurate identification of bacteria and yeast 1-3 days earlier than conventional identification methods. Conventional methods employ sub culturing, overnight incubation and phenotypic identification that can take days and lead to empiric therapy coverage with broad-spectrum antibiotics until results become available. With QuickFISH, results are available in just 20 minutes from the positive blood culture, enabling clinicians to optimize antibiotic therapy sooner.

More Less

About us

Company details

AdvanDx, an OpGen company, is a market leader in molecular diagnostics testing of positive blood cultures, enabling clinical microbiology labs to report pathogen identification results 48 to 72 hours earlier than with conventional testing methods. The unique QuickFISH® technology for Staphylococcus, Enterococcus, Gram-Negative Rods and Candida species is the only technology quick enough to allow pathogen reporting with Gram-stain results. When used by physicians and pharmacists to ensure early, appropriate antibiotic therapy for patients with bloodstream infections (a.k.a. septicemia), AdvanDx’s PNA FISH® and QuickFISH® tests have been shown in clinical studies to reduce patient mortality, shorten length of stay (LOS) and lower hospital costs. Our mission is to help healthcare providers optimize antibiotic therapy earlier in order to improve patient outcomes while limiting unnecessary antibiotic use and reducing hospital costs.

More Less